Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital for hospitalization duration in non-hemolytic neonatal jaundice
IRCT2016052628090N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Aug 2014
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of phenobarbital in neonatal hyperbilirubinemia, sponsored by Qazvin University of Medical Sciences. Started Aug 2014; status: completed.
02
Drugs
phenobarbital
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT2016052628090N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016052628090N1.